A multicentre randomised phase III trial comparing atezolizumab plus bevacizumab and standard chemotherapy versus bevacizumab and standard chemotherapy as first-line treatment in advanced malignant pleural mesothelioma

ETOP BEAT-meso

Studienleiter

Dr. med.
Amina
Scherz
Inselspital Bern
+41 31 362 21 11

Für Informationen zur Studie besuchen Sie bitte die ETOP-Webseite www.etop-eu.org.

Alle Studien